Concepts (297)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Otolaryngology | 10 | 2020 | 12 | 3.560 |
Why?
|
| Bibliometrics | 4 | 2014 | 8 | 1.600 |
Why?
|
| Humans | 49 | 2020 | 6794 | 1.550 |
Why?
|
| Biomedical Research | 5 | 2014 | 34 | 1.360 |
Why?
|
| Tonsillectomy | 4 | 2013 | 4 | 1.220 |
Why?
|
| Financing, Government | 4 | 2014 | 10 | 1.180 |
Why?
|
| Publishing | 3 | 2013 | 11 | 1.170 |
Why?
|
| Head and Neck Neoplasms | 4 | 2016 | 13 | 1.000 |
Why?
|
| Research Support as Topic | 4 | 2014 | 20 | 0.970 |
Why?
|
| Male | 25 | 2019 | 3671 | 0.960 |
Why?
|
| United States | 17 | 2019 | 1019 | 0.910 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2015 | 82 | 0.900 |
Why?
|
| Thyroid Diseases | 3 | 2014 | 25 | 0.900 |
Why?
|
| Female | 24 | 2019 | 4060 | 0.890 |
Why?
|
| Retrospective Studies | 13 | 2020 | 681 | 0.850 |
Why?
|
| Postoperative Hemorrhage | 3 | 2013 | 5 | 0.830 |
Why?
|
| Protein Aggregates | 1 | 2023 | 1 | 0.830 |
Why?
|
| Authorship | 2 | 2014 | 3 | 0.830 |
Why?
|
| Thyroidectomy | 2 | 2014 | 6 | 0.820 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2023 | 18 | 0.810 |
Why?
|
| Adolescent | 13 | 2017 | 869 | 0.780 |
Why?
|
| Periodicals as Topic | 2 | 2013 | 12 | 0.770 |
Why?
|
| Otorhinolaryngologic Diseases | 2 | 2019 | 2 | 0.690 |
Why?
|
| Health Care Costs | 3 | 2020 | 30 | 0.680 |
Why?
|
| Device Removal | 1 | 2020 | 1 | 0.670 |
Why?
|
| Catheterization | 1 | 2020 | 7 | 0.670 |
Why?
|
| Spinal Cord Injuries | 1 | 2020 | 8 | 0.670 |
Why?
|
| Medicare | 4 | 2015 | 57 | 0.640 |
Why?
|
| Adult | 13 | 2018 | 2113 | 0.610 |
Why?
|
| Postoperative Complications | 4 | 2014 | 109 | 0.600 |
Why?
|
| Practice Guidelines as Topic | 3 | 2014 | 84 | 0.580 |
Why?
|
| Child | 7 | 2017 | 524 | 0.530 |
Why?
|
| Guidelines as Topic | 2 | 2017 | 19 | 0.530 |
Why?
|
| Primary Health Care | 2 | 2017 | 78 | 0.520 |
Why?
|
| Middle Aged | 13 | 2019 | 2108 | 0.510 |
Why?
|
| Bacterial Infections | 2 | 2014 | 12 | 0.500 |
Why?
|
| National Institutes of Health (U.S.) | 2 | 2014 | 8 | 0.500 |
Why?
|
| von Willebrand Diseases | 2 | 2013 | 2 | 0.470 |
Why?
|
| Health Services Research | 2 | 2013 | 27 | 0.470 |
Why?
|
| Internet | 2 | 2013 | 25 | 0.470 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2015 | 49 | 0.470 |
Why?
|
| Fee-for-Service Plans | 1 | 2015 | 8 | 0.460 |
Why?
|
| Otorhinolaryngologic Neoplasms | 1 | 2015 | 1 | 0.450 |
Why?
|
| Research Design | 1 | 2015 | 41 | 0.440 |
Why?
|
| Skull Fractures | 2 | 2012 | 3 | 0.440 |
Why?
|
| Women | 1 | 2014 | 4 | 0.430 |
Why?
|
| Medical Oncology | 1 | 2014 | 10 | 0.420 |
Why?
|
| Retropharyngeal Abscess | 1 | 2014 | 1 | 0.420 |
Why?
|
| Peritonsillar Abscess | 1 | 2014 | 2 | 0.420 |
Why?
|
| Robotics | 1 | 2014 | 3 | 0.420 |
Why?
|
| Soft Tissue Infections | 1 | 2014 | 7 | 0.420 |
Why?
|
| Clinical Trials as Topic | 1 | 2014 | 54 | 0.420 |
Why?
|
| Risk Assessment | 5 | 2018 | 197 | 0.420 |
Why?
|
| Hospitals, High-Volume | 1 | 2013 | 2 | 0.410 |
Why?
|
| Esophagoscopy | 1 | 2013 | 4 | 0.410 |
Why?
|
| Bronchoscopy | 1 | 2013 | 3 | 0.410 |
Why?
|
| Inpatients | 1 | 2013 | 22 | 0.400 |
Why?
|
| Disclosure | 1 | 2013 | 3 | 0.400 |
Why?
|
| Conflict of Interest | 1 | 2013 | 2 | 0.400 |
Why?
|
| Quality Improvement | 1 | 2013 | 31 | 0.400 |
Why?
|
| Neck Dissection | 1 | 2013 | 1 | 0.400 |
Why?
|
| Publications | 1 | 2013 | 5 | 0.400 |
Why?
|
| Models, Anatomic | 1 | 2013 | 8 | 0.400 |
Why?
|
| Hemophilia A | 1 | 2013 | 1 | 0.390 |
Why?
|
| Research | 1 | 2013 | 26 | 0.390 |
Why?
|
| Patient Education as Topic | 2 | 2014 | 58 | 0.390 |
Why?
|
| Patient Protection and Affordable Care Act | 2 | 2014 | 4 | 0.390 |
Why?
|
| Education, Medical, Graduate | 1 | 2013 | 28 | 0.390 |
Why?
|
| Child, Preschool | 5 | 2014 | 258 | 0.390 |
Why?
|
| Drug Industry | 1 | 2012 | 5 | 0.380 |
Why?
|
| Public Policy | 1 | 2012 | 8 | 0.380 |
Why?
|
| Comprehension | 1 | 2012 | 7 | 0.380 |
Why?
|
| Smell | 1 | 2012 | 2 | 0.370 |
Why?
|
| Maxillofacial Injuries | 1 | 2012 | 1 | 0.360 |
Why?
|
| Free Tissue Flaps | 1 | 2012 | 7 | 0.360 |
Why?
|
| Wounds, Gunshot | 1 | 2012 | 15 | 0.360 |
Why?
|
| Ear, Inner | 1 | 2011 | 2 | 0.360 |
Why?
|
| Alzheimer Disease | 1 | 2012 | 30 | 0.360 |
Why?
|
| Electronic Health Records | 1 | 2012 | 34 | 0.350 |
Why?
|
| Endothelium, Vascular | 1 | 2011 | 30 | 0.350 |
Why?
|
| Skull Fracture, Basilar | 1 | 2011 | 1 | 0.350 |
Why?
|
| Carotid Artery Injuries | 1 | 2011 | 3 | 0.350 |
Why?
|
| Temporal Bone | 1 | 2011 | 2 | 0.350 |
Why?
|
| Multiple Trauma | 1 | 2011 | 5 | 0.350 |
Why?
|
| Cervical Vertebrae | 1 | 2011 | 4 | 0.350 |
Why?
|
| Brain Injuries | 1 | 2011 | 12 | 0.340 |
Why?
|
| Hearing Loss, Bilateral | 1 | 2011 | 1 | 0.340 |
Why?
|
| Adenoidectomy | 1 | 2011 | 1 | 0.340 |
Why?
|
| Blood Coagulation Disorders | 1 | 2011 | 4 | 0.340 |
Why?
|
| Treatment Outcome | 5 | 2018 | 500 | 0.340 |
Why?
|
| Cohort Studies | 6 | 2015 | 285 | 0.330 |
Why?
|
| Young Adult | 5 | 2017 | 567 | 0.330 |
Why?
|
| Endolymphatic Sac | 1 | 2010 | 1 | 0.320 |
Why?
|
| Mastoid | 1 | 2010 | 1 | 0.320 |
Why?
|
| Meniere Disease | 1 | 2010 | 1 | 0.320 |
Why?
|
| Rhinitis, Allergic, Perennial | 1 | 2010 | 1 | 0.320 |
Why?
|
| Sinusitis | 1 | 2010 | 4 | 0.320 |
Why?
|
| Hearing Loss | 1 | 2010 | 13 | 0.310 |
Why?
|
| Databases, Factual | 4 | 2015 | 81 | 0.310 |
Why?
|
| Follow-Up Studies | 5 | 2016 | 268 | 0.310 |
Why?
|
| Cross-Sectional Studies | 4 | 2017 | 506 | 0.310 |
Why?
|
| Chondroma | 1 | 2009 | 1 | 0.300 |
Why?
|
| Enchondromatosis | 1 | 2009 | 1 | 0.300 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 2009 | 1 | 0.300 |
Why?
|
| Petrous Bone | 1 | 2009 | 1 | 0.300 |
Why?
|
| Sphenoid Sinus | 1 | 2009 | 1 | 0.300 |
Why?
|
| Medicaid | 3 | 2014 | 19 | 0.300 |
Why?
|
| Length of Stay | 3 | 2014 | 53 | 0.290 |
Why?
|
| Respiration, Artificial | 2 | 2020 | 19 | 0.270 |
Why?
|
| Risk Factors | 4 | 2016 | 767 | 0.260 |
Why?
|
| Tracheostomy | 2 | 2020 | 4 | 0.260 |
Why?
|
| Referral and Consultation | 2 | 2019 | 61 | 0.250 |
Why?
|
| Perilymph | 1 | 2006 | 1 | 0.250 |
Why?
|
| Lightning Injuries | 1 | 2006 | 1 | 0.250 |
Why?
|
| Fistula | 1 | 2006 | 2 | 0.250 |
Why?
|
| Cost-Benefit Analysis | 2 | 2018 | 48 | 0.240 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2011 | 57 | 0.240 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 2 | 2019 | 2 | 0.230 |
Why?
|
| Tinnitus | 2 | 2014 | 3 | 0.220 |
Why?
|
| Age Factors | 3 | 2014 | 193 | 0.220 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2016 | 17 | 0.220 |
Why?
|
| Infant | 3 | 2013 | 187 | 0.210 |
Why?
|
| Mitochondrial Dynamics | 1 | 2023 | 1 | 0.210 |
Why?
|
| Organelles | 1 | 2023 | 4 | 0.210 |
Why?
|
| Sex Factors | 3 | 2014 | 155 | 0.210 |
Why?
|
| Cell Division | 1 | 2023 | 40 | 0.210 |
Why?
|
| Mitochondria | 1 | 2023 | 37 | 0.200 |
Why?
|
| Age Distribution | 2 | 2014 | 45 | 0.190 |
Why?
|
| Sex Distribution | 2 | 2014 | 44 | 0.190 |
Why?
|
| Aged | 5 | 2018 | 1539 | 0.180 |
Why?
|
| Severity of Illness Index | 2 | 2014 | 118 | 0.180 |
Why?
|
| Incidence | 2 | 2014 | 197 | 0.180 |
Why?
|
| Audiometry, Pure-Tone | 2 | 2011 | 2 | 0.170 |
Why?
|
| Public Sector | 1 | 2019 | 2 | 0.160 |
Why?
|
| Private Sector | 1 | 2019 | 2 | 0.160 |
Why?
|
| Academic Medical Centers | 1 | 2019 | 23 | 0.160 |
Why?
|
| Endoscopy | 2 | 2010 | 7 | 0.160 |
Why?
|
| Neoplasm Staging | 2 | 2018 | 45 | 0.150 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2010 | 64 | 0.150 |
Why?
|
| Cetuximab | 1 | 2018 | 1 | 0.140 |
Why?
|
| Bevacizumab | 1 | 2018 | 4 | 0.140 |
Why?
|
| Colorectal Neoplasms | 1 | 2018 | 23 | 0.130 |
Why?
|
| Writing | 1 | 2017 | 2 | 0.130 |
Why?
|
| Checklist | 1 | 2017 | 2 | 0.130 |
Why?
|
| Medical Records | 1 | 2017 | 23 | 0.130 |
Why?
|
| Comorbidity | 2 | 2015 | 147 | 0.130 |
Why?
|
| Insurance, Health | 2 | 2014 | 26 | 0.120 |
Why?
|
| Neoplasms, Second Primary | 1 | 2016 | 1 | 0.120 |
Why?
|
| Asia | 2 | 2014 | 3 | 0.120 |
Why?
|
| Budgets | 2 | 2014 | 4 | 0.120 |
Why?
|
| SEER Program | 1 | 2016 | 9 | 0.120 |
Why?
|
| Prognosis | 2 | 2018 | 220 | 0.120 |
Why?
|
| Hypophysectomy | 1 | 2015 | 1 | 0.120 |
Why?
|
| Pituitary ACTH Hypersecretion | 1 | 2015 | 1 | 0.120 |
Why?
|
| ACTH-Secreting Pituitary Adenoma | 1 | 2015 | 1 | 0.120 |
Why?
|
| Radiotherapy | 1 | 2015 | 4 | 0.120 |
Why?
|
| Dopamine Agonists | 1 | 2015 | 3 | 0.120 |
Why?
|
| Adrenalectomy | 1 | 2015 | 10 | 0.120 |
Why?
|
| Adenoma | 1 | 2015 | 7 | 0.120 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2015 | 3 | 0.120 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2015 | 7 | 0.120 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2015 | 8 | 0.120 |
Why?
|
| Risk | 1 | 2015 | 43 | 0.110 |
Why?
|
| Asthma | 1 | 2015 | 31 | 0.110 |
Why?
|
| Prevalence | 2 | 2016 | 259 | 0.110 |
Why?
|
| Orthopedic Procedures | 1 | 2014 | 3 | 0.110 |
Why?
|
| Eligibility Determination | 1 | 2014 | 4 | 0.110 |
Why?
|
| Neck | 1 | 2014 | 3 | 0.110 |
Why?
|
| Cooperative Behavior | 1 | 2014 | 28 | 0.110 |
Why?
|
| Thyroid Nodule | 1 | 2014 | 3 | 0.110 |
Why?
|
| Operative Time | 1 | 2014 | 8 | 0.100 |
Why?
|
| Postoperative Care | 1 | 2014 | 8 | 0.100 |
Why?
|
| Pain, Postoperative | 1 | 2014 | 19 | 0.100 |
Why?
|
| Specialization | 1 | 2014 | 17 | 0.100 |
Why?
|
| Health Expenditures | 1 | 2014 | 16 | 0.100 |
Why?
|
| Costs and Cost Analysis | 1 | 2013 | 16 | 0.100 |
Why?
|
| Thyroid Neoplasms | 1 | 2014 | 15 | 0.100 |
Why?
|
| Total Quality Management | 1 | 2013 | 1 | 0.100 |
Why?
|
| Michigan | 1 | 2013 | 7 | 0.100 |
Why?
|
| Surgery Department, Hospital | 1 | 2013 | 1 | 0.100 |
Why?
|
| Organ Sparing Treatments | 1 | 2013 | 3 | 0.100 |
Why?
|
| Financial Support | 1 | 2013 | 2 | 0.100 |
Why?
|
| Access to Information | 1 | 2013 | 4 | 0.100 |
Why?
|
| Cost Savings | 1 | 2013 | 13 | 0.100 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2013 | 9 | 0.100 |
Why?
|
| Hypothyroidism | 1 | 2014 | 48 | 0.100 |
Why?
|
| MEDLINE | 1 | 2013 | 5 | 0.100 |
Why?
|
| Health Care Surveys | 1 | 2013 | 28 | 0.100 |
Why?
|
| Equipment Design | 1 | 2013 | 20 | 0.100 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 42 | 0.100 |
Why?
|
| Socioeconomic Factors | 1 | 2013 | 197 | 0.100 |
Why?
|
| Health Services Accessibility | 1 | 2014 | 145 | 0.100 |
Why?
|
| Hospitalization | 1 | 2014 | 128 | 0.100 |
Why?
|
| Quality Control | 1 | 2012 | 2 | 0.100 |
Why?
|
| Organizations, Nonprofit | 1 | 2012 | 3 | 0.100 |
Why?
|
| Prospective Studies | 1 | 2013 | 331 | 0.090 |
Why?
|
| Taxes | 1 | 2012 | 2 | 0.090 |
Why?
|
| Cosmetic Techniques | 1 | 2012 | 4 | 0.090 |
Why?
|
| American Recovery and Reinvestment Act | 1 | 2012 | 1 | 0.090 |
Why?
|
| Mandibular Injuries | 1 | 2012 | 1 | 0.090 |
Why?
|
| Jaw Fixation Techniques | 1 | 2012 | 1 | 0.090 |
Why?
|
| Nose | 1 | 2012 | 2 | 0.090 |
Why?
|
| Fascia | 1 | 2012 | 3 | 0.090 |
Why?
|
| Bone Wires | 1 | 2012 | 2 | 0.090 |
Why?
|
| Bone Transplantation | 1 | 2012 | 2 | 0.090 |
Why?
|
| Fracture Fixation, Internal | 1 | 2012 | 2 | 0.090 |
Why?
|
| Bone Plates | 1 | 2012 | 2 | 0.090 |
Why?
|
| Orbit | 1 | 2012 | 6 | 0.090 |
Why?
|
| Insurance Coverage | 1 | 2012 | 14 | 0.090 |
Why?
|
| Debridement | 1 | 2012 | 5 | 0.090 |
Why?
|
| Skin Transplantation | 1 | 2012 | 3 | 0.090 |
Why?
|
| Medical Informatics | 1 | 2012 | 8 | 0.090 |
Why?
|
| Delivery of Health Care | 1 | 2012 | 71 | 0.090 |
Why?
|
| Quality Assurance, Health Care | 1 | 2012 | 17 | 0.090 |
Why?
|
| Hyperplasia | 1 | 2011 | 6 | 0.090 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2011 | 5 | 0.090 |
Why?
|
| Graft Survival | 1 | 2012 | 36 | 0.090 |
Why?
|
| Motivation | 1 | 2012 | 42 | 0.090 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 127 | 0.090 |
Why?
|
| Cerebral Angiography | 1 | 2011 | 1 | 0.090 |
Why?
|
| Glasgow Coma Scale | 1 | 2011 | 3 | 0.090 |
Why?
|
| Societies, Medical | 1 | 2012 | 67 | 0.090 |
Why?
|
| Thyroid Gland | 1 | 2011 | 28 | 0.090 |
Why?
|
| Physicians | 1 | 2012 | 49 | 0.090 |
Why?
|
| Facial Dermatoses | 1 | 2011 | 1 | 0.090 |
Why?
|
| Clinical Competence | 1 | 2011 | 51 | 0.090 |
Why?
|
| Granuloma | 1 | 2011 | 6 | 0.090 |
Why?
|
| Bone Diseases, Developmental | 1 | 2011 | 1 | 0.090 |
Why?
|
| Cochlear Implants | 1 | 2011 | 1 | 0.090 |
Why?
|
| Ear Canal | 1 | 2011 | 1 | 0.090 |
Why?
|
| Hypertelorism | 1 | 2011 | 1 | 0.090 |
Why?
|
| Incus | 1 | 2011 | 1 | 0.090 |
Why?
|
| Speech Perception | 1 | 2011 | 1 | 0.090 |
Why?
|
| Otologic Surgical Procedures | 1 | 2011 | 1 | 0.090 |
Why?
|
| Hyperostosis | 1 | 2011 | 1 | 0.090 |
Why?
|
| Craniofacial Abnormalities | 1 | 2011 | 1 | 0.090 |
Why?
|
| Organophosphonates | 1 | 2011 | 6 | 0.090 |
Why?
|
| Cytosine | 1 | 2011 | 7 | 0.090 |
Why?
|
| Off-Label Use | 1 | 2011 | 3 | 0.090 |
Why?
|
| Tympanic Membrane | 1 | 2011 | 3 | 0.090 |
Why?
|
| Emergency Treatment | 1 | 2011 | 2 | 0.080 |
Why?
|
| Partial Thromboplastin Time | 1 | 2011 | 3 | 0.080 |
Why?
|
| Blood Transfusion | 1 | 2011 | 8 | 0.080 |
Why?
|
| Hospitals, Pediatric | 1 | 2011 | 11 | 0.080 |
Why?
|
| Analysis of Variance | 1 | 2011 | 63 | 0.080 |
Why?
|
| Antiviral Agents | 1 | 2011 | 53 | 0.080 |
Why?
|
| Tracheitis | 1 | 2010 | 2 | 0.080 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2010 | 3 | 0.080 |
Why?
|
| Paranasal Sinuses | 1 | 2010 | 1 | 0.080 |
Why?
|
| Nasal Obstruction | 1 | 2010 | 1 | 0.080 |
Why?
|
| Edema | 1 | 2010 | 6 | 0.080 |
Why?
|
| Hemorrhage | 1 | 2010 | 23 | 0.080 |
Why?
|
| Antineoplastic Agents | 1 | 2011 | 72 | 0.080 |
Why?
|
| Influenza, Human | 1 | 2010 | 18 | 0.080 |
Why?
|
| Wound Healing | 1 | 2009 | 14 | 0.080 |
Why?
|
| Hypopharynx | 1 | 2009 | 1 | 0.080 |
Why?
|
| Larynx | 1 | 2009 | 3 | 0.080 |
Why?
|
| Vascular Malformations | 1 | 2009 | 3 | 0.080 |
Why?
|
| Hearing Loss, Mixed Conductive-Sensorineural | 1 | 2006 | 1 | 0.060 |
Why?
|
| Critical Pathways | 1 | 2019 | 1 | 0.040 |
Why?
|
| Hospitals, Public | 1 | 2019 | 3 | 0.040 |
Why?
|
| Time-to-Treatment | 1 | 2019 | 8 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 2018 | 13 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2018 | 24 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2018 | 22 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2018 | 18 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2018 | 95 | 0.030 |
Why?
|
| Survival Rate | 1 | 2016 | 111 | 0.030 |
Why?
|
| Ketoconazole | 1 | 2015 | 1 | 0.030 |
Why?
|
| Mitotane | 1 | 2015 | 1 | 0.030 |
Why?
|
| Cytochrome P-450 CYP3A Inhibitors | 1 | 2015 | 1 | 0.030 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2015 | 9 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2015 | 54 | 0.030 |
Why?
|
| Hearing Aids | 1 | 2014 | 1 | 0.030 |
Why?
|
| Directive Counseling | 1 | 2014 | 4 | 0.030 |
Why?
|
| Audiometry | 1 | 2014 | 6 | 0.030 |
Why?
|
| New York | 1 | 2014 | 7 | 0.030 |
Why?
|
| Complementary Therapies | 1 | 2014 | 11 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2014 | 140 | 0.030 |
Why?
|
| Accountable Care Organizations | 1 | 2014 | 1 | 0.030 |
Why?
|
| Health Care Reform | 1 | 2014 | 5 | 0.030 |
Why?
|
| Ambulatory Care | 1 | 2014 | 21 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 497 | 0.030 |
Why?
|
| ROC Curve | 1 | 2011 | 28 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2011 | 79 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 112 | 0.020 |
Why?
|
| Injections, Intralesional | 1 | 2011 | 2 | 0.020 |
Why?
|
| Administration, Inhalation | 1 | 2011 | 9 | 0.020 |
Why?
|
| Respiratory Tract Infections | 1 | 2011 | 11 | 0.020 |
Why?
|
| Aerosols | 1 | 2011 | 15 | 0.020 |
Why?
|
| Papillomavirus Infections | 1 | 2011 | 27 | 0.020 |
Why?
|
| Deamino Arginine Vasopressin | 1 | 2010 | 13 | 0.020 |
Why?
|
| Glottis | 1 | 2009 | 1 | 0.020 |
Why?
|
| Laryngeal Mucosa | 1 | 2009 | 1 | 0.020 |
Why?
|
| Facial Transplantation | 1 | 2009 | 1 | 0.020 |
Why?
|
| Skin Physiological Phenomena | 1 | 2009 | 2 | 0.020 |
Why?
|
| Forecasting | 1 | 2009 | 19 | 0.020 |
Why?
|